Back To Search Results

Magnetic Resonance Imaging (MRI) Safety and Biological Effects

Editor: Dawood Tafti Updated: 6/19/2026 2:55:10 AM

Introduction

Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostic medicine, providing high-resolution visualization of internal structures without ionizing radiation. Widespread adoption across nearly all clinical specialties reflects diagnostic versatility and a favorable safety profile. Current evidence indicates that adherence to established safety guidelines does not result in known long-term adverse health effects, although transient and reversible physiologic responses to magnetic, gradient, and radiofrequency fields may occur.

Despite this strong safety record, MRI is not without risk. The powerful static magnetic field, time-varying gradient fields, and radiofrequency energy used during imaging can interact with biological tissues, implanted devices, and external objects, creating potential safety hazards if not properly managed. The increasing complexity of MRI technology, including higher field strengths, advanced imaging sequences, and contrast agent use, necessitates a comprehensive understanding of physical principles and potential biological effects.

Safe MRI practice requires more than knowledge of image acquisition. Rigorous patient screening, careful evaluation of implants and foreign bodies, adherence to standardized safety protocols, and continuous patient monitoring remain essential. Facility design, including controlled access zones, and coordinated interprofessional workflows further contribute to risk reduction. Particular attention is required for vulnerable populations, including pregnant patients and individuals with implanted medical devices, in whom risk–benefit considerations may be more nuanced.

Current research indicates no known long-term adverse health effects from clinical MRI exposure when safety guidelines are followed. Transient, reversible effects related to magnetic, gradient, and radiofrequency fields have been described and are generally well understood and managed.[1] These findings underscore the need for continued investigation of potential long-term biological and health implications.

Assessment of MRI safety should encompass MRI fundamentals, including static magnetic fields, radiofrequency energy, and gradient field effects, as well as screening protocols, monitoring practices, and evaluation methods. Adoption of this comprehensive approach strengthens clinician understanding of MRI biological effects and supports safe and effective clinical application.

This activity provides a comprehensive overview of MRI safety and biological effects, integrating foundational imaging principles with practical clinical considerations. Emphasis is placed on mechanisms of potential harm, risk mitigation strategies, and evidence-based safety practices to support safe and effective use of MRI in contemporary healthcare.

Function

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Function

Basic Principles of Magnetic Resonance Imaging

MRI technology is based on the magnetic properties of hydrogen protons within body tissues. Exposure to a strong magnetic field causes hydrogen protons to behave like miniature magnets and align with the field. Thermal motion prevents perfect alignment, resulting in a measurable net magnetization vector, representing the collective sum of proton magnetic moments within tissue.[2] Net magnetization is essential for MRI signal generation and enables detailed imaging of internal structures. Proton alignment and net magnetization form the fundamental basis of MRI, enabling precise visualization of tissue anatomy and composition.

Relaxation times, specifically T1 and T2, influence image contrast and are indispensable in MRI technology. T1, or longitudinal relaxation time, is the time required for protons to realign with the main magnetic field of the equipment.[3] T2, or transverse relaxation time, is the time required for protons to lose phase coherence perpendicular to this field. Different tissues exhibit distinct T1 and T2 relaxation times, producing variable signal intensities that enable detailed tissue characterization. MRI sequences can be weighted to emphasize these differences: T1-weighted images render tissues with shorter T1 times brighter, whereas T2-weighted images highlight tissues with longer T2 times. Proton-density weighting reflects variations in hydrogen proton concentration across tissues.[4] Adjustment of imaging sequences allows tailoring of scans to specific clinical indications.

MRI can acquire both 2- and 3-dimensional images. In 2-dimensional imaging, slice selection, along with frequency and phase encoding gradients, defines individual image planes. In contrast, 3-dimensional imaging uses an additional phase-encoding dimension to acquire volumetric data, enabling high-resolution imaging and multiplanar reconstruction.[5]

Sampling of k-space is a fundamental determinant of MRI image contrast and resolution. Acquisition strategies, such as spiral sampling from the center outward, influence both image quality and tissue contrast.[6] Advanced pulse sequences, including gradient echo and spin echo, manipulate proton behavior to generate images with distinct characteristics: Gradient echo sequences demonstrate faster acquisition and increased sensitivity to magnetic field inhomogeneities, whereas spin echo sequences provide superior tissue contrast.[7]

Gadolinium-based contrast agents (GBCAs) enhance MRI by altering local proton relaxation properties, thereby increasing contrast and improving visualization of vascular structures and pathologic tissues. Optimization of imaging parameters, in conjunction with contrast administration, enables precise and comprehensive evaluation across a wide range of clinical indications.

Biological and Health Effects of Magnetic Resonance Imaging

The energy frequencies used in clinical MRI are lower than those of x-rays, visible light, and microwaves. Tissue heating occurs primarily through absorption of radiofrequency energy, with greater energy deposition at higher frequencies. Thermoregulation depends on convection, conduction, radiation, and evaporation, processes that are more efficient in individuals with higher surface-area-to-volume ratios. Sequences involving repeated radiofrequency pulses, such as fast spin echo, may increase energy deposition and raise concerns for radiofrequency-related heating, although clinically significant effects are uncommon when safety limits are observed.[8] Clinically significant heating is rare with modern scanner design and adherence to specific absorption rate limits.

Magnetic field strength in MRI is measured in gauss and kilogauss, with higher strengths expressed in Tesla. Field strengths up to 3.0 Tesla are widely used in clinical practice and are considered safe when appropriate protocols are followed. Reversible effects, such as electrocardiographic (ECG) changes, have been reported and are thought to result from the magnetohydrodynamic effect of blood flow within the magnetic field, potentially interfering with cardiac gating in high-field scanners.[9] Field strengths of 7.0 Tesla and above are primarily research tools, and safety profiles continue to undergo evaluation.

Contrary to earlier concerns, no established evidence indicates that clinical MRI field strengths cause DNA damage or clinically significant alterations in intracellular molecules, such as hemoglobin. During MRI procedures, small electrical potentials may develop in large blood vessels secondary to blood flow within the static magnetic field.[10] Most studies demonstrate no significant effects on cell growth or morphology at field strengths up to 3.0 Tesla.[11] The relationship between electromagnetic fields and carcinogenesis remains inconclusive, although current evidence does not support a causal association with clinical MRI exposure.[12]

The 5-gauss line defines the boundary at which magnetic field strength decreases to levels generally considered safe for public exposure. Field strengths above this threshold may pose risks, including interference with implanted medical devices, particularly with prolonged exposure. This boundary is typically clearly delineated within MRI facilities.

Screening for Magnetic Resonance Imaging

Implementation of a meticulous screening process protects all individuals accessing the areas surrounding MRI equipment. The process involves detailed questioning and education of patients and staff to ensure a safe environment. The most reliable method of preventing MRI-related health risks is thorough screening of patients and MRI personnel.[13] Individuals with potential ferromagnetic foreign objects within or on the body require comprehensive evaluation to prevent injury or adverse events.

All individuals, including patients, volunteers, visitors, MRI healthcare workers, and cleaning staff, require structured screening by qualified personnel before entry into MRI zones. Routine service checks and ongoing education are essential components of safe MRI operation. Careful MRI facility management and regular maintenance are critical to maintaining a safe environment. Most MRI-related injuries result from inadequate screening.[14] However, adherence to standardized screening protocols varies, and no universal consensus exists regarding the optimal screening protocol.[15] The American College of Radiology released a major update to its MRI Safety Manual in 2025, reorganizing and expanding guidance on screening protocols, roles of MRI personnel (MRI Medical Director, MRI Safety Officer, MRI Safety Expert), and emergency procedures.[16]

Safety Zones for Magnetic Resonance Imaging

The MRI safety zones represent graduated levels of restriction as individuals approach the scanner. Zone I includes areas where the MRI magnetic field poses no hazard to patients, with no restrictions on movement required. This zone typically encompasses hospital hallways leading to the MRI department and publicly accessible areas. Zone II generally includes the MRI department waiting areas and, in many facilities, dressing rooms, where patient movement is unrestricted. Zone III represents a restricted area located immediately beyond the MRI scanning room. This zone commonly includes the control room where MRI technologists operate the scanner, requiring controlled access due to proximity to the magnetic field. Zone IV corresponds to the MRI scanner room itself, where the strongest magnetic field is present and where the highest level of risk exists. Strict safety precautions and controlled access are required within this zone to ensure patient and staff safety.

Magnetic Resonance Imaging Screening Form

A detailed questionnaire for patients and staff assists in identifying potential adverse reactions to exposure to strong magnetic fields. The form should include questions regarding prior surgeries, metallic foreign body injuries, and pregnancy status. Presence of implants, materials, devices, or objects susceptible to magnetic field interactions must be documented, including electrically, magnetically, or mechanically activated devices. Inclusion of a body diagram indicating implant locations enhances risk identification. The form may also capture relevant history of prior adverse reactions to contrast media.

Magnetic Resonance Imaging Screening Interview

Verbal interviews are necessary when written questionnaires have limited utility. Language barriers, as well as visual or literacy limitations, may produce incomplete or inaccurate written responses. A verbal interview addresses these limitations when conducted in the individual’s native language. MRI technologists or trained staff may further ensure safety by clarifying and confirming responses. The oral screening phase is essential for verifying the reliability of any provided information.

Prescreening for Metallic Implants

Each MRI facility requires a standardized MRI screening policy for individuals with suspected foreign metallic implants or devices. The policy should apply regardless of MRI system field strength, magnet type, or the presence of magnetic shielding. Protocols for radiographic evaluation and assessment of the risks posed by metallic objects in strong magnetic fields must be clearly defined.[17]

Considerations in Pregnant Patients

MRI in pregnancy is generally recommended to avoid ionizing radiation exposure, such as that from computed tomography or fluoroscopy, or to aid evaluation when alternative nonionizing diagnostic methods are insufficient. Risk–benefit assessment is required in patients who are pregnant or may be pregnant. MRI enables fetal imaging in multiple planes and allows evaluation of large fetal and placental fields of view with high-resolution detail. Reduced ionizing radiation exposure contributes to the increasing use of MRI in obstetric imaging.[18]

Concerns regarding MRI safety in pregnancy persist, particularly with administration of GBCAs.[19] Safety of MRI and gadolinium exposure during pregnancy remains under active investigation due to potential fetal risks.[20] GBCAs cross the placental barrier, raising theoretical concerns regarding fetal exposure. Concern is greatest during the 1st trimester because of the potential for teratogenic effects.[21]

Magnetic Resonance Imaging Safety for Patients with Ancillary Equipment and Implants

Ancillary equipment must meet 1 of 3 criteria: manufacturer safety declaration, approval from the US Food and Drug Administration, or prior testing. “Manufacturer declaration” indicates that the equipment has been tested for MRI safety by the manufacturer.[22] Metallic implants may experience significant torque within magnetic fields, posing risk if not adequately secured. Implant material determines the extent of interaction with the magnetic field. Strong magnetic fields may cause significant deflection of ferromagnetic metals. Nonferromagnetic metals tend to accumulate heat in the MRI environment due to radiofrequency absorption.[23]

Patient surgical history must be obtained prior to MRI, particularly in cases involving implanted devices. Even in the absence of significant clinical effects, implants may produce MRI artifacts that can lead to image misinterpretation. Implant material and size influence artifact magnitude.[24]

Clear understanding of interactions between medical implants, foreign bodies, and the MRI environment is essential for maintaining patient safety while preserving image quality. MRI safety depends largely on device material composition, fixation, and anatomical location, with ferromagnetic components posing the greatest risk due to potential displacement, torque, or heating.

Aneurysm clip safety depends strongly on composition. Ferromagnetic clips, such as stainless steel, are contraindicated, whereas nonferromagnetic materials, such as titanium, are generally considered safe once verified. MRI with aneurysm clips should proceed only after confirmation of nonferromagnetic composition.[25] Hemostatic vascular clips and most carotid artery clamps are typically nonferromagnetic and safe, although rare exceptions exist, such as the Poppen-Blaylock clamp.[26][27] Intravascular devices, including coils, filters, and stents, may contain ferromagnetic elements but are generally safe after endothelialization, which reduces migration risk.[28]

Most vascular access ports and prosthetic heart valves demonstrate minimal magnetic interaction and are considered safe in clinical MRI settings.[29] MRI is generally safe for patients with prosthetic heart valves, including devices previously considered hazardous, such as the Starr-Edwards Model Pre-6000.[30] Orthopedic implants and materials similarly demonstrate negligible displacement or heating and rarely present safety concerns.[31]

Dental materials and external devices may produce image artifacts but are generally safe unless ferromagnetic components are present.[32] Otologic and cochlear implants require device-specific verification, as MRI compatibility depends on model and field strength. Otologic implants approved for 3-Tesla MRI systems include Baha and Ponto Pro osseointegrated implants, as well as Sophono Alpha 1 and 2 implanted magnets. Cochlear implants with removable magnets are approved for 1.5-Tesla MRI, provided that magnetic components are removed prior to scanning.[33] Penile implants rarely present significant risk, although patient discomfort requires consideration.

Ocular implants and intraocular ferromagnetic foreign bodies warrant particular caution due to the risk of movement and injury. Appropriate screening, often with radiography, is essential. Certain ocular implants, such as eyelid springs and retinal tacks, may exhibit magnetic attraction and pose risks of ocular discomfort or injury during MRI studies. Appropriate screening and protective measures are recommended when these implants are present.[34] Metallic fragments within the eye pose a risk due to magnetic field–induced movement. Small fragments may be detected via radiography, which is generally sufficient for identifying metallic fragments with potential for injury. However, computed tomography provides greater sensitivity than radiography.[35] Retained metallic fragments, including bullets, pellets, or shrapnel, require individualized risk assessment based on composition, location, and proximity to critical structures.[36]

Safe MRI practice requires device-specific verification, comprehensive screening, and strict adherence to established safety guidelines. Assumptions based solely on device category are unreliable.

Considerations in Patients with Pacemakers

MRI use in patients with cardiac pacemakers has historically been limited due to safety concerns. Although previously considered contraindicated, the development of MRI-conditional pacemakers now permits imaging in appropriately selected patients under specific protocols.[37] These devices may be scanned safely under MRI, although specific energy and scanning parameters require careful control.[38] Standardized protocols should be implemented to ensure patient safety, including prescan and postscan device evaluation and continuous monitoring during the procedure.[39]

MRI is often essential for diagnostic accuracy. However, in patients with pacemakers, potential benefits must be carefully weighed against associated risks. Management requires close coordination between radiology and cardiology teams, along with strict adherence to device-specific safety protocols.

Assessment and Monitoring During Magnetic Resonance Imaging Examinations

Patients undergoing MRI require continuous visual and verbal monitoring. MRI technologists should interact with patients before, during, and after the procedure. Patients unable to communicate, such as those with sedation, coma, advanced age–related limitations, hearing impairment, or language barriers, require additional physiologic monitoring.

The selection of monitoring methods depends on patient condition, clinical indication, MRI procedure type, and available equipment. Monitoring options include visual assessment, pulse rate monitoring, ECG, respiratory rate monitoring, pulse oximetry, capnography, and temperature measurement. Patients undergoing sedation or anesthesia require appropriate monitoring to detect and manage potential adverse drug reactions.[40][41]

Magnetic resonance–safe monitoring devices, defined as instruments that do not interfere with MRI processes, are available. Magnetic resonance–safe electrodes should be used during cardiovascular MRI, where ECG-based gating is required to ensure safety and data accuracy. Sedated patients require pulse oximetry monitoring, as magnetohydrodynamic effects may produce ECG artifacts, and many sedative agents depress respiration.[42]

Claustrophobia is a recognized concern during MRI due to radiofrequency heating, gradient noise, and spatial confinement. Persistent claustrophobia may develop following MRI exposure and may require psychiatric intervention.[43] Controllable airflow within the magnet bore, along with clear patient communication and preprocedure education, may reduce the incidence and severity of these reactions.

Considerations When Using Gadolinium-Based Contrast Agents

Gadolinium is the most frequently used MRI contrast agent. Adverse effects associated with gadolinium are generally minimal but may include transient elevations in bilirubin and serum iron, headache, nausea, and anaphylaxis.[44] Gadolinium chelates are administered via intravenous injection, followed by a saline flush. Gadolinium chelates are generally safe, with few absolute contraindications. However, caution is advised in individuals with sickle cell disease, renal failure, and known allergies, as well as in women who are pregnant or lactating.

Issues of Concern

Emergency Procedures for Magnetic Resonance Imaging Environments

The most critical step in medical or technical MRI emergencies is prompt removal of the patient from the scan room. Immediate transfer to a safer location is required to eliminate exposure to the strong magnetic field. Provision of emergency medical care within the MRI scan room is hazardous due to the magnetic properties of most crash cart equipment.[45]

Emergencies such as fire or quench events, defined as sudden loss of superconductivity in the MRI magnet with rapid helium release, require immediate patient evacuation.[46] Manual quench is indicated in 2 situations: a large fire posing a threat to human life and, rarely, a ferromagnetic object causing patient entrapment at the scanner.

Evacuation Protocol

Running a code or emergency resuscitation within the MRI environment is strongly discouraged. Use of ferromagnetic objects, such as monitors and defibrillators, near high-field MRI equipment may cause injury to both patients and healthcare personnel. A designated area outside the MRI scan room must be established for medical emergencies, allowing healthcare teams to provide care without the risk of magnetic interference. The designated area should be appropriately prepared and equipped to support full resuscitation procedures.

A code event does not constitute an indication for MRI magnet quench. Emergency resuscitation is typically performed in Zone II.

Clinical Significance

MRI safety has direct implications for real-time clinical decision-making and patient outcomes, particularly in high-risk or complex scenarios. Although MRI is generally safe, errors in screening, device assessment, or protocol execution can cause immediate, serious complications, making safety practices clinically consequential rather than theoretical.

Appropriate patient positioning and coil placement are essential for obtaining diagnostic-quality MRI images while maintaining patient comfort and safety. Patients should be positioned according to the anatomic region and examination being performed, with the area of interest centered appropriately within the selected coil. Immobilization and positioning aids may be used to minimize motion and improve image quality. Proper positioning is particularly important in patients with claustrophobia, obesity, pediatric patients, and those requiring sedation, as positioning may affect both patient tolerance and the ability to obtain adequate images.

A key clinical role of MRI safety is preventing avoidable harm during routine care. Inadequate screening for ferromagnetic materials or implanted devices may result in device malfunction, tissue injury, or projectile events. Unrecognized risks associated with radiofrequency energy, such as conductive loops or external conductive materials, may cause burns. These events are uncommon but are most often associated with system-level failures, emphasizing the need for reliable workflows rather than dependence on individual vigilance alone.

MRI safety also influences modality selection and diagnostic strategy. Patients with non–MRI-compatible implants or uncertain device status may require alternative imaging modalities, such as computed tomography or ultrasound, even when MRI would otherwise provide superior diagnostic information. Therefore, safety considerations may alter diagnostic accuracy, timing, and downstream clinical management.

MRI introduces additional challenges in patients who have critical illness or are sedated. Limited patient communication increases the risk of unrecognized complications, requiring enhanced monitoring and coordination between radiology and critical care teams. In pregnant patients, MRI is often preferred over ionizing imaging modalities. However, decisions regarding contrast administration and timing require individualized assessment, reflecting a balance between diagnostic yield and potential risks.

From a systems perspective, MRI safety functions as a high-reliability process. Structured screening protocols, controlled access to magnet environments, and clear delineation of team responsibilities are essential for maintaining safety at scale. Breakdowns most commonly occur during transitions of care, including order entry, handoffs, or incomplete documentation, highlighting the importance of consistent communication across specialties.

The clinical significance of MRI safety lies in its impact on immediate patient protection and broader diagnostic decision-making. Effective safety practices support appropriate MRI utilization across diverse clinical settings while minimizing preventable adverse events.

Enhancing Healthcare Team Outcomes

MRI is a high-value diagnostic modality that provides detailed anatomic and functional information without ionizing radiation. However, safe MRI use depends on careful management of technology-specific risks. MRI operates through interactions between strong magnetic fields, radiofrequency energy, and tissue protons, producing transient physiologic effects such as heating or nerve stimulation. Clinically significant adverse events are uncommon and are typically preventable, most often resulting from inadequate screening and the presence of unrecognized ferromagnetic materials or device incompatibility. Proper evaluation requires thorough preimaging assessment of implants, foreign bodies, and patient-specific risk factors, along with consideration of contrast-related risks in vulnerable populations. Understanding and addressing these factors improves both MRI safety and diagnostic effectiveness.

An interprofessional approach is essential to optimize outcomes and minimize risk. Radiologists, referring physicians, and safety experts collaborate to establish and implement screening and monitoring protocols, while technologists and physicists ensure proper equipment function and image quality. Nurses and advanced practitioners play key roles in patient preparation, education, and physiologic monitoring, particularly in high-risk or sedated patients. Pharmacists and nephrologists support safe GBCAs use through risk assessment and mitigation strategies. Coordinated team responses are critical in emergencies, given the unique hazards of the MRI environment. Effective communication, shared decision-making, and clearly defined roles across disciplines support timely diagnosis, reduce preventable complications, and promote patient-centered care.

References


[1]

Hartwig V, Giovannetti G, Vanello N, Lombardi M, Landini L, Simi S. Biological effects and safety in magnetic resonance imaging: a review. International journal of environmental research and public health. 2009 Jun:6(6):1778-98. doi: 10.3390/ijerph6061778. Epub 2009 Jun 10     [PubMed PMID: 19578460]


[2]

Grover VP, Tognarelli JM, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ. Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians. Journal of clinical and experimental hepatology. 2015 Sep:5(3):246-55. doi: 10.1016/j.jceh.2015.08.001. Epub 2015 Aug 20     [PubMed PMID: 26628842]


[3]

Azhar S, Chong LR. Clinician's guide to the basic principles of MRI. Postgraduate medical journal. 2023 Jul 21:99(1174):894-903. doi: 10.1136/pmj-2022-141998. Epub     [PubMed PMID: 37130816]


[4]

Serai SD. Basics of magnetic resonance imaging and quantitative parameters T1, T2, T2*, T1rho and diffusion-weighted imaging. Pediatric radiology. 2022 Feb:52(2):217-227. doi: 10.1007/s00247-021-05042-7. Epub 2021 Apr 15     [PubMed PMID: 33856502]


[5]

Wild JM, Woodhouse N, Paley MN, Fichele S, Said Z, Kasuboski L, van Beek EJ. Comparison between 2D and 3D gradient-echo sequences for MRI of human lung ventilation with hyperpolarized 3He. Magnetic resonance in medicine. 2004 Sep:52(3):673-8     [PubMed PMID: 15334590]


[6]

Xiang QS, Henkelman RM. K-space description for MR imaging of dynamic objects. Magnetic resonance in medicine. 1993 Mar:29(3):422-8     [PubMed PMID: 8383792]


[7]

Markl M, Leupold J. Gradient echo imaging. Journal of magnetic resonance imaging : JMRI. 2012 Jun:35(6):1274-89. doi: 10.1002/jmri.23638. Epub     [PubMed PMID: 22588993]


[8]

Taso M, Munsch F, Girard OM, Duhamel G, Alsop DC, Varma G. Fast-spin-echo versus rapid gradient-echo for 3D magnetization-prepared acquisitions: Application to inhomogeneous magnetization transfer. Magnetic resonance in medicine. 2023 Feb:89(2):550-564. doi: 10.1002/mrm.29461. Epub 2022 Oct 28     [PubMed PMID: 36306334]


[9]

Mirza IA, Abdulhameed M, Vieru D, Shafie S. Transient electro-magneto-hydrodynamic two-phase blood flow and thermal transport through a capillary vessel. Computer methods and programs in biomedicine. 2016 Dec:137():149-166. doi: 10.1016/j.cmpb.2016.09.014. Epub 2016 Sep 23     [PubMed PMID: 28110721]


[10]

Gowland PA. Present and future magnetic resonance sources of exposure to static fields. Progress in biophysics and molecular biology. 2005 Feb-Apr:87(2-3):175-83     [PubMed PMID: 15556657]


[11]

Norimura T, Imada H, Kunugita N, Yoshida N, Nikaido M. Effects of strong magnetic fields on cell growth and radiation response of human T-lymphocytes in culture. Journal of UOEH. 1993 Jun 1:15(2):103-12     [PubMed PMID: 8316709]


[12]

Bortkiewicz A. Health effects of Radiofrequency Electromagnetic Fields (RF EMF). Industrial health. 2019:57(4):403-405. doi: 10.2486/indhealth.57_400. Epub     [PubMed PMID: 31378769]


[13]

Sammet S. Magnetic resonance safety. Abdominal radiology (New York). 2016 Mar:41(3):444-51. doi: 10.1007/s00261-016-0680-4. Epub     [PubMed PMID: 26940331]


[14]

Sawyer-Glover AM, Shellock FG. Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. Journal of magnetic resonance imaging : JMRI. 2000 Jul:12(1):92-106     [PubMed PMID: 10931569]


[15]

Sharma PS, Saindane AM. Standardizing Magnetic Resonance Imaging Protocols Across a Large Radiology Enterprise: Barriers and Solutions. Current problems in diagnostic radiology. 2020 Sep-Oct:49(5):312-316. doi: 10.1067/j.cpradiol.2020.01.012. Epub 2020 Feb 12     [PubMed PMID: 32173157]


[16]

Kanal E. The Updated ACR Manual on MR Safety and How It Will Affect Your Practice. Radiology. 2025 Apr:315(1):e242954. doi: 10.1148/radiol.242954. Epub     [PubMed PMID: 40167437]


[17]

Ziegeler K, Yoon D, Hoff M, Theologis AA. Metal Suppression Magnetic Resonance Imaging Techniques in Orthopaedic and Spine Surgery. The Journal of the American Academy of Orthopaedic Surgeons. 2025 May 15:33(10):510-517. doi: 10.5435/JAAOS-D-24-01057. Epub 2025 Mar 11     [PubMed PMID: 40063737]


[18]

Puris G, Chetrit A, Katorza E. Fetal Safety in MRI During Pregnancy: A Comprehensive Review. Diagnostics (Basel, Switzerland). 2025 Jan 17:15(2):. doi: 10.3390/diagnostics15020208. Epub 2025 Jan 17     [PubMed PMID: 39857092]


[19]

Lum M, Tsiouris AJ. MRI safety considerations during pregnancy. Clinical imaging. 2020 Jun:62():69-75. doi: 10.1016/j.clinimag.2020.02.007. Epub 2020 Feb 20     [PubMed PMID: 32109683]


[20]

Mervak BM, Altun E, McGinty KA, Hyslop WB, Semelka RC, Burke LM. MRI in pregnancy: Indications and practical considerations. Journal of magnetic resonance imaging : JMRI. 2019 Mar:49(3):621-631. doi: 10.1002/jmri.26317. Epub 2019 Jan 31     [PubMed PMID: 30701610]


[21]

Gatta G, Di Grezia G, Cuccurullo V, Sardu C, Iovino F, Comune R, Ruggiero A, Chirico M, La Forgia D, Fanizzi A, Massafra R, Belfiore MP, Falco G, Reginelli A, Brunese L, Grassi R, Cappabianca S, Viola L. MRI in Pregnancy and Precision Medicine: A Review from Literature. Journal of personalized medicine. 2021 Dec 23:12(1):. doi: 10.3390/jpm12010009. Epub 2021 Dec 23     [PubMed PMID: 35055324]


[22]

Kopanoglu E, Steckner M, Hoff MN, Campbell-Washburn AE, Webb AG, Reeder SB, Gulani V, ISMRM Safety Committee. MRI and Implant Safety at Low-Field and Ultralow-Field Strengths. Journal of magnetic resonance imaging : JMRI. 2026 Feb:63(2):364-377. doi: 10.1002/jmri.70168. Epub 2025 Dec 19     [PubMed PMID: 41416779]


[23]

Peschke E, Ulloa P, Jansen O, Hoevener JB. Metallic Implants in MRI - Hazards and Imaging Artifacts. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2021 Nov:193(11):1285-1293. doi: 10.1055/a-1460-8566. Epub 2021 May 12     [PubMed PMID: 33979870]


[24]

Jabehdar Maralani P, Schieda N, Hecht EM, Litt H, Hindman N, Heyn C, Davenport MS, Zaharchuk G, Hess CP, Weinreb J. MRI safety and devices: An update and expert consensus. Journal of magnetic resonance imaging : JMRI. 2020 Mar:51(3):657-674. doi: 10.1002/jmri.26909. Epub 2019 Sep 30     [PubMed PMID: 31566852]

Level 3 (low-level) evidence

[25]

Hofman MBM, Lavini C, van der Zwan A, van Pul C, Muller SH, Stam MK, van der Graaf M, Kloeze C, van Nierop BJ, Kappert P, Kuijer JPA. MRI in patients with a cerebral aneurysm clip; review of the literature and incident databases and recommendations for the Netherlands. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2024 Jan:117():103187. doi: 10.1016/j.ejmp.2023.103187. Epub 2023 Nov 27     [PubMed PMID: 38016215]


[26]

Seymour T, Jazayeri SB, Ghozy S, Rinaldo L, Kadirvel R. A comprehensive review of aneurysm clip materials and artifact reduction techniques. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2025 Oct 25:():15910199251387204. doi: 10.1177/15910199251387204. Epub 2025 Oct 25     [PubMed PMID: 41137661]


[27]

Teitelbaum GP, Lin MC, Watanabe AT, Norfray JF, Young TI, Bradley WG Jr. Ferromagnetism and MR imaging: safety of carotid vascular clamps. AJNR. American journal of neuroradiology. 1990 Mar-Apr:11(2):267-72     [PubMed PMID: 2107710]


[28]

Ng PP, Yam PK, Poon WL. MRI Safety for Interventional Radiologists: A Narrative Review for MRI-Guided Interventions. Cureus. 2026 Jan:18(1):e101084. doi: 10.7759/cureus.101084. Epub 2026 Jan 8     [PubMed PMID: 41664721]

Level 3 (low-level) evidence

[29]

Titterington B, Shellock FG. Evaluation of MRI issues for an access port with a radiofrequency identification (RFID) tag. Magnetic resonance imaging. 2013 Oct:31(8):1439-44. doi: 10.1016/j.mri.2013.04.005. Epub 2013 May 16     [PubMed PMID: 23684963]


[30]

Karamitsos TD, Karvounis H. Magnetic resonance imaging is a safe technique in patients with prosthetic heart valves and coronary stents. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2019 Jan-Feb:60(1):38-39. doi: 10.1016/j.hjc.2017.12.001. Epub 2017 Dec 29     [PubMed PMID: 29292243]


[31]

Mosher ZA, Sawyer JR, Kelly DM. MRI Safety with Orthopedic Implants. The Orthopedic clinics of North America. 2018 Oct:49(4):455-463. doi: 10.1016/j.ocl.2018.05.010. Epub 2018 Aug 16     [PubMed PMID: 30224007]


[32]

Wilson BJ, O'hare PE, Zacariah J. Implications and Considerations of Dental Materials in MRI: A Case Report and Literature Review. Case reports in dentistry. 2020:2020():8891302. doi: 10.1155/2020/8891302. Epub 2020 Dec 15     [PubMed PMID: 33381327]


[33]

Azadarmaki R, Tubbs R, Chen DA, Shellock FG. MRI information for commonly used otologic implants: review and update. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2014 Apr:150(4):512-9. doi: 10.1177/0194599813518306. Epub 2014 Jan 7     [PubMed PMID: 24398365]


[34]

Yuh WT, Hanigan MT, Nerad JA, Ehrhardt JC, Carter KD, Kardon RH, Shellock FG. Extrusion of eye socket magnetic implant after MR imaging: potential hazard to patient with eye prosthesis. Journal of magnetic resonance imaging : JMRI. 1991 Nov-Dec:1(6):711-3     [PubMed PMID: 1823177]


[35]

Williams S, Char DH, Dillon WP, Lincoff N, Moseley M. Ferrous intraocular foreign bodies and magnetic resonance imaging. American journal of ophthalmology. 1988 Apr 15:105(4):398-401     [PubMed PMID: 3282439]


[36]

Hecht S, Adams WH, Narak J, Thomas WB. Magnetic resonance imaging susceptibility artifacts due to metallic foreign bodies. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 2011 Jul-Aug:52(4):409-14. doi: 10.1111/j.1740-8261.2011.01809.x. Epub 2011 Mar 7     [PubMed PMID: 21382122]


[37]

Bovenschulte H, Schlüter-Brust K, Liebig T, Erdmann E, Eysel P, Zobel C. MRI in patients with pacemakers: overview and procedural management. Deutsches Arzteblatt international. 2012 Apr:109(15):270-5. doi: 10.3238/arztebl.2012.0270. Epub 2012 Apr 13     [PubMed PMID: 22567062]

Level 3 (low-level) evidence

[38]

Lanz H, Strauß K, Höpler J, Kraft M, Hoffmann S, Binzenhöfer L, Gade N, Roden D, Saleh I, Kääb S, Lackermair K, Sadoni S, Hagl C, Massberg S, Estner H, Fichtner S, Lüsebrink E. Safety of Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices. Journal of cardiovascular development and disease. 2024 Oct 8:11(10):. doi: 10.3390/jcdd11100313. Epub 2024 Oct 8     [PubMed PMID: 39452284]


[39]

Lebel K, Mondesert B, Robillard J, Pham M, Terrone D, Tan S. 2020 MR Safety for Cardiac Devices: An Update for Radiologists. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 2021 Nov:72(4):814-830. doi: 10.1177/0846537120967701. Epub 2020 Nov 24     [PubMed PMID: 33231493]


[40]

Maurer WG, Walsh M, Viazis N. Basic requirements for monitoring sedated patients: blood pressure, pulse oximetry, and EKG. Digestion. 2010:82(2):87-9. doi: 10.1159/000285505. Epub 2010 Apr 21     [PubMed PMID: 20407251]


[41]

Holshouser BA, Hinshaw DB Jr, Shellock FG. Sedation, anesthesia, and physiologic monitoring during MR imaging: evaluation of procedures and equipment. Journal of magnetic resonance imaging : JMRI. 1993 May-Jun:3(3):553-8     [PubMed PMID: 8324317]


[42]

Taber KH, Thompson J, Coveler LA, Hayman LA. Invasive pressure monitoring of patients during magnetic resonance imaging. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1993 Nov:40(11):1092-5     [PubMed PMID: 8269573]


[43]

Lawal O, Regelous P, Omiyi D. Supporting claustrophobic patients during Magnetic Resonance Imaging examination- the patient perspective. Radiography (London, England : 1995). 2023 Oct:29(6):1108-1114. doi: 10.1016/j.radi.2023.09.008. Epub 2023 Sep 27     [PubMed PMID: 37774577]

Level 3 (low-level) evidence

[44]

Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR. American journal of roentgenology. 1996 Oct:167(4):847-9     [PubMed PMID: 8819369]

Level 3 (low-level) evidence

[45]

Doda Khera R, Hirsch JA, Buch K, Saini S. ED MRI: Safety, Consent, and Regulatory Considerations. Magnetic resonance imaging clinics of North America. 2022 Aug:30(3):553-563. doi: 10.1016/j.mric.2022.04.011. Epub     [PubMed PMID: 35995479]


[46]

Association of Anaesthetists of Great Britain and Ireland, Farling PA, Flynn PA, Darwent G, De Wilde J, Grainger D, King S, McBrien ME, Menon DK, Ridgway JP, Sury M, Thornton J, Wilson SR. Safety in magnetic resonance units: an update. Anaesthesia. 2010 Jul:65(7):766-70. doi: 10.1111/j.1365-2044.2010.06377.x. Epub     [PubMed PMID: 20642539]